[1]
S. Baldini, L. Rigacci, V. Carrai, R. Alterini, R. Fjerza, and A. Bosi, “PATIENTS WITH ≥ 20 X 109/L PLATELETS AT BASELINE MAY HAVE A PROMPT RESPONSE TO ROMIPLOSTIM DURING THE EARLY PHASE OF TREATMENT: AN ITALIAN SINGLE-INSTITUTION EXPERIENCE”, MJHID, vol. 4, no. 1, p. e2012044, Jun. 2012.